[go: up one dir, main page]

AU2001247667A1 - Adsorption of polyampholytes to charged surfaces and assays incorporating same - Google Patents

Adsorption of polyampholytes to charged surfaces and assays incorporating same

Info

Publication number
AU2001247667A1
AU2001247667A1 AU2001247667A AU4766701A AU2001247667A1 AU 2001247667 A1 AU2001247667 A1 AU 2001247667A1 AU 2001247667 A AU2001247667 A AU 2001247667A AU 4766701 A AU4766701 A AU 4766701A AU 2001247667 A1 AU2001247667 A1 AU 2001247667A1
Authority
AU
Australia
Prior art keywords
polyampholytes
adsorption
charged surfaces
incorporating same
assays incorporating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247667A
Inventor
Kenneth Mcleod
Nadine Pernodet
Miriam Rafailovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of AU2001247667A1 publication Critical patent/AU2001247667A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU2001247667A 2000-03-21 2001-03-21 Adsorption of polyampholytes to charged surfaces and assays incorporating same Abandoned AU2001247667A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19080600P 2000-03-21 2000-03-21
US60190806 2000-03-21
PCT/US2001/009129 WO2001070762A2 (en) 2000-03-21 2001-03-21 Adsorption of polyampholytes to charged surfaces and assays incorporating same

Publications (1)

Publication Number Publication Date
AU2001247667A1 true AU2001247667A1 (en) 2001-10-03

Family

ID=22702860

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247667A Abandoned AU2001247667A1 (en) 2000-03-21 2001-03-21 Adsorption of polyampholytes to charged surfaces and assays incorporating same

Country Status (3)

Country Link
US (1) US6686144B2 (en)
AU (1) AU2001247667A1 (en)
WO (1) WO2001070762A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380290A1 (en) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-beta structure pathway and its therapeutic relevance
US20070003552A1 (en) * 2002-07-09 2007-01-04 Gebbink Martijn F B Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation
US20040025191A1 (en) * 2002-07-31 2004-02-05 B. Popular, Inc. System and method for creating and presenting content packages
US8268974B2 (en) 2003-05-29 2012-09-18 Academia Sinica Process to produce fibrillar proteins
US20090202980A1 (en) * 2005-03-21 2009-08-13 Crossbeta Biosciences B.V. Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation
BRPI0613525A2 (en) * 2005-07-13 2011-05-31 Crossbeta Biosciences Bv methods for producing an immunogenic composition, for enhancing the immunogenicity of a composition, for enhancing the immunogenicity of a vaccine composition, and for determining the amount of beta-cross structures in a vaccine composition, uses of beta-cross structures, and an immunogenic composition, subunit vaccine, and immunogenic composition
EP2386861A3 (en) * 2005-07-13 2012-07-18 Crossbeta Biosciences B.V. Cross-ß structure binding compounds
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
WO2007008073A2 (en) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. METHODS FOR DETERMINING THE EFFECT OF A TREATMENT ON THE CROSS-ß STRUCTURE CONTENT OF A PROTEIN; SELECTION OF TREATMENTS AND USES THEREOF
EP2058000A1 (en) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Immunogenic compositions capable of activating T cells
EP2058001A1 (en) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Enhancement of immunogenicity of antigens
GB2460965B (en) * 2008-03-13 2010-05-19 Academia Sinica Fibrillar albumin and uses thereof
US8373116B2 (en) * 2009-09-21 2013-02-12 Queen's University At Kingston Multi-channel electrospray emitter
US8357652B2 (en) 2009-11-20 2013-01-22 Academia Sinica Anti-tumor fibrillar human serum albumin methods and compositions
US10647953B2 (en) * 2015-02-11 2020-05-12 The Florida State University Research Foundation, Inc. Surface treatment for cell culture

Also Published As

Publication number Publication date
WO2001070762A3 (en) 2002-05-23
US6686144B2 (en) 2004-02-03
WO2001070762A2 (en) 2001-09-27
US20020031758A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001247667A1 (en) Adsorption of polyampholytes to charged surfaces and assays incorporating same
AU2001279796A1 (en) Isolation of glucan particles and uses thereof
AU2002355557A1 (en) Use of isotopes to provide information to an article
SI1379739T1 (en) Construction kit consisting of panel-shaped elements and connecting elements
AU2002323210A1 (en) Bio-synthetic photostimulators and methods of use
AU2003257850A1 (en) ANTIBODY SPECIFIC TO CENTRAL Tau-PROTEIN
AU2001296535A1 (en) High performance nanostructured materials and methods of making the same
AU2002235787A1 (en) Separation of x- and y-sperm cells
AU2003285914A1 (en) Dynamic management of execute in place applications
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001285325A1 (en) Use of threo-methylphenidate compounds to enhance memory
AU2001268701A1 (en) Methods of enhancing adhesion
AU2002314293A1 (en) Application of images to surfaces
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2002308503A1 (en) Relationship to other applications and patents
AU2002356615A1 (en) Novel utilization of cyclopentabenzofurans
AU2002365894A1 (en) Antibodies to magmas and uses thereof
AU2002316552A1 (en) Inhibitor of t cell activation
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2002316577A1 (en) Cell-screening assay and composition
AU2001242765A1 (en) Connection structure of socket wrench
AU2001225856A1 (en) Optimized anaerobic adhesive compositions and methods of preparing same
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002362625A1 (en) Recreation and utility building